BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 7979377)

  • 1. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
    John GH; Hasler JA; He YA; Halpert JR
    Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of residue 480 in substrate specificity of cytochrome P450 2B5 and 2B11.
    Liu J; He YA; Halpert JR
    Arch Biochem Biophys; 1996 Mar; 327(1):167-73. PubMed ID: 8615687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
    Hasler JA; Harlow GR; Szklarz GD; John GH; Kedzie KM; Burnett VL; He YA; Kaminsky LS; Halpert JR
    Mol Pharmacol; 1994 Aug; 46(2):338-45. PubMed ID: 8078495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis study of Asp-290 in cytochrome P450 2B11 using a fusion protein with rat NADPH-cytochrome P450 reductase.
    Harlow GR; Halpert JR
    Arch Biochem Biophys; 1996 Feb; 326(1):85-92. PubMed ID: 8579377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11.
    Waller SC; He YA; Harlow GR; He YQ; Mash EA; Halpert JR
    Chem Res Toxicol; 1999 Aug; 12(8):690-9. PubMed ID: 10458702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
    Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
    Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit liver cytochrome P-450 2B5: high-level expression of the full-length protein in Escherichia coli, purification, and catalytic activity.
    Lehnerer M; Schulze J; Petzold A; Bernhardt R; Hlavica P
    Biochim Biophys Acta; 1995 Aug; 1245(1):107-15. PubMed ID: 7654758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
    Sandhu P; Baba T; Guengerich FP
    Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
    Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
    Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics.
    Chen CS; Lin JT; Goss KA; He YA; Halpert JR; Waxman DJ
    Mol Pharmacol; 2004 May; 65(5):1278-85. PubMed ID: 15102956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
    Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interconversion of the androstenedione hydroxylase specificities of cytochromes P450 2B4 and 2B5 upon simultaneous site-directed mutagenesis of four key substrate recognition residues.
    He YQ; Szklarz GD; Halpert JR
    Arch Biochem Biophys; 1996 Nov; 335(1):152-60. PubMed ID: 8914846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
    Born SL; Fraser DJ; Harlow GR; Halpert JR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):957-63. PubMed ID: 8768753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis.
    Born SL; John GH; Harlow GR; Halpert JR
    Drug Metab Dispos; 1995 Jul; 23(7):702-7. PubMed ID: 7587957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
    Dong J; Porter TD
    Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies.
    He YQ; He YA; Halpert JR
    Chem Res Toxicol; 1995 Jun; 8(4):574-9. PubMed ID: 7548737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
    Grimm SW; Dyroff MC; Philpot RM; Halpert JR
    Mol Pharmacol; 1994 Dec; 46(6):1090-9. PubMed ID: 7808429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of cytochrome P450 2B2: catalytic specificity and identification of four active site residues.
    Strobel SM; Halpert JR
    Biochemistry; 1997 Sep; 36(39):11697-706. PubMed ID: 9305959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.